| Willard C Arnold, DO | |
|
625 James S Trimble Blvd, Paintsville, KY 41240-1055 | |
| (606) 789-3511 | |
| (606) 789-1432 |
| Full Name | Willard C Arnold |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 625 James S Trimble Blvd, Paintsville, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134108855 | NPI | - | NPPES |
| 0333071 | Medicaid | OH | |
| 5600426-000 | Medicaid | WV | |
| 000000205500 | Other | KY | BLUECROSS BLUESHIELD |
| 64021165 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 02116 (Kentucky) | Primary |
| Entity Name | Southeastern Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356379382 PECOS PAC ID: 2466364997 Enrollment ID: O20050302000285 |
News Archive
Epilepsy Therapy Project, a leader in accelerating new therapies for people living with epilepsy and seizures, announces the release of My Epilepsy Diary, a breakthrough data-gathering and reporting product designed to improve epilepsy care and quality of life.
The use of PET-CT imaging gives doctors the best possible picture of non-small cell lung cancer, and this accurate imaging helps to match patients with the best treatments.
Researchers report SARS-CoV-2 antibodies to the spike protein (S protein) can persist 200 days after symptom onset, but that antibodies to the nucleoprotein (N protein) can reduce much more rapidly.
ZIOPHARM Oncology, Inc. today announced the initiation of the pivotal Phase III clinical trial for palifosfamide in patients with front-line metastatic soft tissue sarcoma. The study, called PICASSO 3, is an international, randomized, double-blinded, placebo-controlled trial designed to enroll approximately 424 patients with metastatic soft tissue sarcoma who have never been treated with chemotherapy for metastatic disease.
› Verified 6 days ago
| Entity Name | Combs Mountain Emergency Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629603527 PECOS PAC ID: 9335579515 Enrollment ID: O20200501000614 |
News Archive
Epilepsy Therapy Project, a leader in accelerating new therapies for people living with epilepsy and seizures, announces the release of My Epilepsy Diary, a breakthrough data-gathering and reporting product designed to improve epilepsy care and quality of life.
The use of PET-CT imaging gives doctors the best possible picture of non-small cell lung cancer, and this accurate imaging helps to match patients with the best treatments.
Researchers report SARS-CoV-2 antibodies to the spike protein (S protein) can persist 200 days after symptom onset, but that antibodies to the nucleoprotein (N protein) can reduce much more rapidly.
ZIOPHARM Oncology, Inc. today announced the initiation of the pivotal Phase III clinical trial for palifosfamide in patients with front-line metastatic soft tissue sarcoma. The study, called PICASSO 3, is an international, randomized, double-blinded, placebo-controlled trial designed to enroll approximately 424 patients with metastatic soft tissue sarcoma who have never been treated with chemotherapy for metastatic disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Willard C Arnold, DO Po Box 409013, Atlanta, GA 30384-9013 Ph: (800) 377-8721 | Willard C Arnold, DO 625 James S Trimble Blvd, Paintsville, KY 41240-1055 Ph: (606) 789-3511 |
News Archive
Epilepsy Therapy Project, a leader in accelerating new therapies for people living with epilepsy and seizures, announces the release of My Epilepsy Diary, a breakthrough data-gathering and reporting product designed to improve epilepsy care and quality of life.
The use of PET-CT imaging gives doctors the best possible picture of non-small cell lung cancer, and this accurate imaging helps to match patients with the best treatments.
Researchers report SARS-CoV-2 antibodies to the spike protein (S protein) can persist 200 days after symptom onset, but that antibodies to the nucleoprotein (N protein) can reduce much more rapidly.
ZIOPHARM Oncology, Inc. today announced the initiation of the pivotal Phase III clinical trial for palifosfamide in patients with front-line metastatic soft tissue sarcoma. The study, called PICASSO 3, is an international, randomized, double-blinded, placebo-controlled trial designed to enroll approximately 424 patients with metastatic soft tissue sarcoma who have never been treated with chemotherapy for metastatic disease.
› Verified 6 days ago
Thomas B. Styer, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 625 James S. Trimble Blvd., Paintsville, KY 41240 Phone: 606-789-3511 Fax: 606-789-1432 | |
Gary A. Lowther, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 625 James S. Trimble Blvd., Paintsville, KY 41240 Phone: 606-789-3511 Fax: 606-789-1432 | |
Hassan Helwani, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 625 James S Trimble Blvd, Paintsville, KY 41240 Phone: 606-789-3511 Fax: 606-789-1432 | |
Lisa C Cain, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 625 James S Trimble Blvd, Paintsville, KY 41240 Phone: 606-789-3511 |